Microbial limit testing for sanitary napkins is a critical quality control procedure that verifies the microbiological safety of disposable feminine hygiene products before they reach consumers. This article explains the applicable standards such as GB 15979 and GB/T 8939, the required test items including total bacterial count and specified pathogens, sample preparation and testing methods, and the acceptance criteria used by manufacturers and accredited third-party laboratories.
Technical Overview
Sanitary napkins (sanitary pads) are disposable hygiene products that remain in direct and prolonged contact with the vulvar skin and mucous membranes, an anatomical region that is warm, moist, and highly susceptible to microbial irritation or infection. Consequently, the microbiological quality of these products is regulated far more strictly than that of ordinary consumer goods. Microbial limit testing is the laboratory procedure used to enumerate the total microbial burden of a sanitary napkin and to demonstrate the absence of specified pathogenic organisms.
In China, the hygienic requirements for disposable sanitary products are governed by GB 15979 (Hygienic Standard for Disposable Sanitary Products), while the product performance specification for sanitary napkins and panty liners is defined in GB/T 8939. Internationally, equivalent microbiological examination procedures are described in compendial and ISO methods, such as USP Chapter 61 and Chapter 62, the corresponding pharmacopoeial microbial limit chapters, and the ISO 21149, ISO 16212, ISO 21150, ISO 22717, and ISO 22718 series originally developed for cosmetic microbiology. Manufacturers exporting sanitary napkins often have products tested against both GB requirements and the compendial methods required in the destination market.
The objective of the test is twofold: first, to quantify aerobic bacteria and fungi present on or in the product, and second, to confirm that indicator and pathogenic organisms are absent in a defined sample quantity. Results must fall below the acceptance limits in the applicable standard before a production lot can be released.
Testing Samples
Finished Products
The primary test object is the finished sanitary napkin or panty liner, sampled from a production lot using a statistically representative sampling plan. Samples are drawn unopened from intact retail or bulk packaging, handled with sterile gloves and instruments, and transported to the laboratory in sterile containers. Testing is normally initiated as soon as possible after sampling to prevent changes in the microbial population. A typical submission consists of 10 or more units (or a minimum of 10 g of product material) per lot.
Raw Materials and Components
Individual materials may also be submitted for microbial limit testing, including fluff pulp, superabsorbent polymer (SAP), nonwoven topsheets, hot-melt adhesives, release paper, and packaging films. Incoming material testing helps manufacturers identify contamination at its source and supports supplier qualification programs, since finished-product bioburden is strongly influenced by raw material quality.
Environmental and In-Process Samples
Although not part of the product microbial limit itself, hygiene monitoring samples from the production environment, such as air settle plates, contact plates from equipment surfaces, and swabs from operator gloves, are frequently tested alongside finished products. These data help determine whether any finished-product non-conformance originates from the manufacturing environment.
Testing Items
The test panel for sanitary napkins reflects the requirements of GB 15979 for disposable sanitary products. The standard test items are listed below; the specific numeric limits depend on the product grade and the edition of the standard in force.
- Total aerobic bacterial count (aerobic plate count, commonly required not to exceed 200 CFU/g for ordinary-grade products)
- Total fungal count, including yeasts and molds (commonly required not to exceed 100 CFU/g for ordinary-grade products)
- Coliform bacteria and Escherichia coli (must not be detected)
- Staphylococcus aureus (must not be detected)
- Pseudomonas aeruginosa (must not be detected)
- Hemolytic Streptococcus, in particular Streptococcus pyogenes (must not be detected)
- Candida albicans, required by certain specifications and export markets
- Initial microbial contamination level (bioburden) for products subjected to a disinfection step, where stricter limits such as a total count not exceeding 20 CFU/g and no detectable fungi apply to disinfection-grade products
Limits are typically expressed per gram of product or per unit area, and the detection of specified organisms is judged on a defined sample portion, for example absence in 1 g. Because GB 15979 was revised with a newer edition replacing the 2002 version, testing programs should always be verified against the current edition and any market-specific regulatory requirements.
Testing Methods
Sample Preparation
The sanitary napkin is opened aseptically in a laminar-flow or biosafety cabinet. The absorbent body and contact surfaces are cut into small pieces with sterile scissors, weighed, and transferred into a sterile diluent such as 0.9% sodium chloride solution or buffered peptone water. Because sanitary napkins may contain preservatives, antibacterial agents, or disinfectant residues, a neutralizing diluent containing lecithin and polysorbate 80 is frequently used to eliminate residual antimicrobial activity. The suspension is homogenized, typically with a stomacher or shaker, to release microorganisms from the fibrous matrix, and ten-fold serial dilutions are prepared.
Total Count Methods
The total aerobic bacterial count is determined by the plate pour method or spread plate method using plate count agar or nutrient agar, with incubation at approximately 30 to 37 °C for 24 to 72 hours. The total combined yeasts and molds count is determined on Sabouraud dextrose agar supplemented with antibacterial antibiotics, incubated at approximately 20 to 28 °C for 3 to 7 days. Colonies are counted, and results are calculated by multiplying the average count by the dilution factor and expressed as CFU per gram. For products expected to carry a very low bioburden, the membrane filtration method is preferred, as it allows a large volume of the initial suspension to be examined and improves detection sensitivity.
Detection of Specified Microorganisms
Pathogen screening follows a enrichment, isolation, and confirmation sequence. Coliforms and E. coli are enriched in lauryl sulfate tryptose broth or MacConkey broth and isolated on MacConkey or eosin methylene blue agar, with confirmation by biochemical tests or chromogenic media. Staphylococcus aureus is enriched in tryptic soy broth, isolated on Baird-Parker agar or mannitol salt agar, and confirmed by the coagulase and DNase tests. Pseudomonas aeruginosa is isolated on cetrimide agar and confirmed by oxidase reaction and pigment production. Hemolytic streptococci are enriched in brain heart infusion broth and examined on blood agar for beta-hemolysis. Candida albicans is enriched in Sabouraud dextrose broth, isolated on chromogenic Candida agar, and confirmed by the germ-tube test. Presumptive colonies may also be identified with commercial biochemical or MALDI-based identification systems.
Controls and Method Suitability
Each test run includes negative controls (diluent and media blanks) and positive controls using certified reference strains, such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli, Candida albicans, and Aspergillus brasiliensis. Before a routine method is adopted, a method suitability (bacteriostasis and fungistasis) validation is performed by inoculating the sample with low levels of each strain to demonstrate that the product itself does not inhibit microbial recovery. Recovery comparable to the control, typically within 0.5 log units, is required for the method to be considered valid.
Rapid and Alternative Methods
Where faster results are needed for release testing or trending, validated rapid microbiological methods may be used, including ATP bioluminescence for hygiene screening, fluorescence-based auto-fluorescence detection, flow cytometry, and polymerase chain reaction (PCR) assays for rapid pathogen detection. Such methods require validation against the compendial or standard reference method before being used for lot disposition.
Applications
Microbial limit testing of sanitary napkins supports quality, regulatory, and commercial objectives across the product lifecycle. Typical applications include:
- Batch release testing of finished production lots against GB 15979 and GB/T 8939 requirements
- Regulatory compliance demonstrations for domestic market surveillance authorities and for product filing or registration
- Import and export verification, where destination markets require compendial microbiological methods
- Compliance evidence required by retail chains and e-commerce platforms for feminine hygiene products
- Raw material and supplier qualification, and evaluation of incoming fluff pulp, SAP, and nonwoven fabrics
- Hygiene control programs in manufacturing, correlating environmental monitoring with finished product results
- Investigation of consumer complaints, out-of-specification results, or product recall support
- Shelf-life and stability studies verifying that microbiological quality is maintained through the labeled expiry date
Testing is performed by in-house quality control laboratories or by accredited third-party laboratories with microbiological competence recognized under ISO/IEC 17025 accreditation.
FAQ
Why do sanitary napkins require microbial limit testing when they are not sterile products?
Although sanitary napkins are not required to be sterile, they contact sensitive mucous membranes for extended periods. Regulators therefore impose maximum allowable microbial counts and prohibit pathogenic organisms, because even non-sterile products with excessive or dangerous bioburden can cause irritation, urinary or genital infections, and other health risks.
Which standards define the microbial limits for sanitary napkins?
In China, GB 15979 defines the hygienic and microbiological requirements for disposable sanitary products, and GB/T 8939 defines the sanitary napkin product specification that references it. For international markets, microbiological enumeration and pathogen detection are commonly performed according to USP Chapters 61 and 62, the corresponding European pharmacopoeial chapters, or ISO methods such as ISO 21149 and ISO 16212.
What are the typical acceptance criteria?
For ordinary-grade products under the widely applied GB 15979 requirements, the total aerobic bacterial count is typically limited to no more than 200 CFU/g and the total fungal count to no more than 100 CFU/g, while specified organisms including coliforms, Staphylococcus aureus, Pseudomonas aeruginosa, and hemolytic streptococci must be absent in the tested quantity. Disinfection-grade products are subject to stricter limits. Always confirm the limits against the current edition of the standard and the requirements of the target market.
How is a sanitary napkin sample prepared for testing?
The product is opened aseptically, cut into small pieces, weighed, and homogenized in a sterile diluent, often with lecithin and polysorbate 80 added to neutralize any antimicrobial residues. The homogenized suspension and its serial dilutions are then used for plate counts, membrane filtration, or pathogen enrichment procedures.
How much sample is required and how long does testing take?
A typical submission requires 10 or more finished units or at least 10 g of material per lot. Because detection of specified organisms requires enrichment, selective isolation, and confirmatory testing, the standard turnaround time is usually 7 to 10 working days from receipt of the sample.
What happens if a product exceeds the microbial limits?
An out-of-specification result triggers an investigation covering sampling and laboratory error, raw materials, environmental hygiene, and production conditions. The affected lot must not be released unless the result is invalidated by a documented laboratory investigation, and corrective actions such as enhanced sanitation, supplier change, or process requalification are implemented to prevent recurrence.
